When was First Light Diagnostics founded?

First Light Diagnostics was founded in 2007 and raised its 1st funding round within a year of its incorporation.

Where is First Light Diagnostics located?

First Light Diagnostics is headquartered in Chelmsford, United States. It is registered at 2 Omni Way Chelmsford, MA 01824 USA.

Who is the current CEO of First Light Diagnostics?

David Macdonald of First Light Diagnostics.

How many employees does First Light Diagnostics have?

As of Dec 31, 2020, First Light Diagnostics has 33 employees, reflecting a 35% year-over-year decline in headcount.

Is First Light Diagnostics a funded company?

First Light Diagnostics is a funded company, having raised a total of $17.4M across 21 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 15, 2007.

When was the latest funding round of First Light Diagnostics?

First Light Diagnostics' latest funding was a $***** Grant (prize money) round on Oct 27, 2020, with participation from 1 investor. Its primary sector is Infectious Diseases. In United States, the Infectious Diseases sector has seen $407M in funding in 2026 to date.

Where does First Light Diagnostics rank among its competitors?

First Light Diagnostics ranks 32nd amongst 335 active competitors, of which 80 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was HaystackAnalytics, which secured $5M in Sep, 2025.

Who are the top competitors of First Light Diagnostics?

First Light Diagnostics' top competitors include Adaptive Biotechnologies, MeMed and Inflammatix. Among them, HaystackAnalytics secured the most recent funding round in September, 2025.

First Light Diagnostics - 2026 Company Profile, Team, Funding & Competitors

First Light Diagnostics is a series A company based in Chelmsford (United States), founded in 2007. It operates as a Rapid diagnostics for antibiotic resistance, enabling faster, targeted therapy decisions. First Light Diagnostics has raised $17.4M in funding from investors like Beacon Angels, Think.Health and 10x Group. The company has 335 active competitors, including 80 funded and 50 that have exited. Its top competitors include companies like Adaptive Biotechnologies, MeMed and Inflammatix.

Company Details

Rapid diagnostics for antibiotic resistance, enabling faster, targeted therapy decisions. This company is focused on revolutionizing rapid microbiology with its innovative platform technology. Their culture-free antimicrobial susceptibility testing delivers results in hours, not days, empowering clinicians to make informed therapy decisions at the onset of infection. The platform offers pathogen identification in minutes directly from patient samples, improving patient outcomes and enhancing antibiotic stewardship programs. This technology addresses the critical need for faster and more accurate diagnostics in the fight against antibiotic resistance, ultimately saving lives and improving healthcare.

Website: www.firstlightdx.com/
Social
Email ID: *****@firstlightdx.com
Phone Number: +1 **********
Registered Address: 2 Omni Way Chelmsford, MA 01824 USA

Key Metrics

Founded Year

2007

Location

Chelmsford, United States

Stage

Series A

Total Funding

$17.4M in 21 rounds

Latest Funding Round

Grant (prize money), Oct 27, 2020, $*****

Investors

Beacon Angels & 13 more

Ranked

32^nd among 335 active competitors

Employee Count

33 as on Dec 31, 2020

Similar Companies

Adaptive Biotechnologies & 404 more

View First Light Diagnostics' full profile

First Light Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
First Light Diagnostics, Inc CIN: 20-8121817 , United States, Active	Dec 31, 2006	-	33 (As on Dec 31, 2020)	-

First Light Diagnostics has raised a total funding of $17.4M over 21 rounds. Its first funding round was on Apr 15, 2007. Its latest funding round was a Grant (prize money) round on Oct 27, 2020 for $*****. 1 investor participated in its latest round. First Light Diagnostics has 14 institutional investors.

Here is the list of recent funding rounds of First Light Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 27, 2020	9698753	Grant (prize money)	1828574	7813616	9168767	1348576
Dec 18, 2019	5168303	Grant (prize money)	9154395	2187855	9070066	Public Health Emergency
Jun 19, 2019	6261224	Conventional Debt	9562725	5112637	8185802	MassDevelopment

Access funding benchmarks and valuations. Sign up today!

View details of First Light Diagnostics's funding rounds and investors

First Light Diagnostics' employee count trend

First Light Diagnostics has 33 employees as of Dec 20. The total employee count is 35.0% lower than what it was in Dec 19. Here is First Light Diagnostics's employee count trend over the years:

Employee count trend for First Light Diagnostics

Uncover First Light Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of First Light Diagnostics include Adaptive Biotechnologies, MeMed and Inflammatix. Here is the list of Top 10 competitors of First Light Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	72/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	Inflammatix 2016, San Francisco (United States), Series E	Provider of diagnostic solutions for systemic infections	$191M	Khosla Ventures, Think.Health & 16 others	64/100
4th	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	SINE, STRIVE & 31 others	58/100
5th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Tencent & 16 others	58/100
6th	Clear Labs 2014, Menlo Park (United States), Series D	Provider of food safety technologies for the identification of pathogens	$171M	Menlo Ventures, Redmile Group & 26 others	57/100
7th	Seegene Technologies 2000, Seoul (South Korea), Acquired	Developer of molecular diagnostic kits to detect infectious and genetic diseases	-	IMM Investment, Songhyun Investment & 3 others	57/100
8th	DeepUll 2020, Barcelona (Spain), Series C	Developer of diagnostic solutions for sepsis and acute infections	$92.5M	Columbus Venture Partners, Panakes Partners ... & 14 others	56/100
9th	T2 Biosystems 2006, Lexington (United States), Public	Developer of miniaturized MRI platforms for clinical diagnostics	$454M	Flybridge Capital Partners, Flagship Pioneering ... & 20 others	55/100
10th	Quantamatrix 2010, Seoul (South Korea), Public	Multiplexed platform for disease daignosis	$198K	Treatment Action Group, Shield Investment ... & 6 others	55/100
32nd	First Light Diagnostics 2007, Chelmsford (United States), Series A	Rapid diagnostics for antibiotic resistance, enabling faster, targeted therapy decisions	$17.4M	10x Group, Public Health Emergency & 12 others	45/100